HighTower Advisors’s iShares Biotechnology ETF IBB Stock Holding History

HighTower Advisors’s Portfolio IBB Stock Details IBB Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q1	–	Sell	-1,000	Closed	-$1K	–	2357
2019 Q4	$1K	Buy	+1,000	New	+$112K	﹤0.01%	2262
2019 Q2	–	Sell	-500	Closed	-$1K	–	2444
2019 Q1	$1K	Buy	+500	New	+$54.8K	﹤0.01%	2275
2017 Q1	–	Sell	-48,000	Closed	-$4K	–	2122
2016 Q4	$4K	Buy	+48,000	New	+$4.37M	﹤0.01%	1901
2014 Q2	–	Sell	-1,500	Closed	-$8K	–	1654
2014 Q1	$8K	Buy	+1,500	New	+$125K	﹤0.01%	1530

Other funds holding IBB

Citigroup New York $308B AUM 40.94% 1-Year Est. Return

Morgan Stanley New York $1.96T AUM 27.49% 1-Year Est. Return

BNP Paribas Financial Markets Paris, France $294B AUM 47.59% 1-Year Est. Return

Raymond James Financial St Petersburg, Florida $375B AUM 21.05% 1-Year Est. Return

UBS Group Zurich, Switzerland $765B AUM 28.39% 1-Year Est. Return

LPL Financial San Diego, California $468B AUM 17.69% 1-Year Est. Return

Commerce Bank Kansas City, Missouri $22.9B AUM 22.61% 1-Year Est. Return

JP Morgan Chase New York $1.84T AUM 33.86% 1-Year Est. Return

Truist Financial Charlotte, North Carolina $84.4B AUM 20.16% 1-Year Est. Return

Healthcare of Ontario Pension Plan (HOOPP) Trust Fund Toronto, Ontario, Canada $64.4B AUM 36.06% 1-Year Est. Return

HighTower Advisors's IBB Position: Q3 2026 in Review

HighTower Advisors reduced its iShares Biotechnology ETF (IBB) stake by 3.9% in Q3 2026, selling an estimated $358K and leaving 44,218 shares worth $9.31M. The position accounts for 0.01% of the portfolio, ranked #966.

HighTower Advisors first reported a position in IBB in Q2 2013 and has held it in 54 quarters since. The position peaked at $13M in Q1 2019. 907 funds tracked by Wall St. Rank hold IBB as of Q3 2026.

HighTower Advisors held 44,218 shares of iShares Biotechnology ETF worth $9.31M as of Q3 2026.
HighTower Advisors sold 1,786 iShares Biotechnology ETF shares in Q3 2026, an estimated $358K.
iShares Biotechnology ETF made up 0.01% of HighTower Advisors's portfolio in Q3 2026, its #966 holding.
HighTower Advisors first reported a position in iShares Biotechnology ETF in Q2 2013 and has held it in 54 quarters since.
HighTower Advisors's iShares Biotechnology ETF position peaked at $13M in Q1 2019.
907 funds tracked by Wall St. Rank held iShares Biotechnology ETF as of Q3 2026.

Based on HighTower Advisors's 13F filing for Q3 2026, filed 10 Nov 2026.